Chamigrane-Type Sesquiterpenes from Laurencia dendroidea as Lead Compounds against Naegleria fowleri

Iñigo Arberas-Jiménez1,2, Nathália Nocchi3,4, Javier Chao-Pellicer1,2,5

  • 1Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna (ULL), Avda. Astrofísico Fco. Sánchez, S/N, 38206 La Laguna, Tenerife, Islas Canarias, Spain.

Marine Drugs
|April 27, 2023
PubMed

Insights

Marine natural products show promise against Naegleria fowleri, the cause of primary amoebic meningoencephalitis. The compound (+)-elatol effectively targets both Naegleria fowleri trophozoites and cysts with low toxicity to host cells.

Area of Science:

  • Marine Natural Products Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Naegleria fowleri is an opportunistic protozoon causing primary amoebic meningoencephalitis.
  • Warm water bodies are common habitats for Naegleria fowleri.
  • Developing antiparasitic agents requires identifying novel lead structures.

Purpose of the Study:

  • To identify new anti-Naegleria marine natural products.
  • To evaluate chamigrane-type sesquiterpenes from Laurencia dendroidea.
  • To explore structure-activity relationships for drug development.

Main Methods:

  • Isolation and structural characterization of sesquiterpenes from Laurencia dendroidea.
  • Antiparasitic activity testing against Naegleria fowleri trophozoites and cysts.
  • Cytotoxicity assessment using murine macrophages.

Main Results:

  • (+)-Elatol demonstrated potent activity against Naegleria fowleri trophozoites (IC50 ~1.1 μM) and cysts (IC50 ~1.14 μM).
  • The enantiomer (-)-elatol was significantly less potent (IC50 ~37 μM).
  • (+)-Elatol exhibited low toxicity to murine macrophages and induced programmed cell death markers.

Conclusions:

  • (+)-Elatol is a promising lead compound for developing treatments against primary amoebic meningoencephalitis.
  • Halogenation and lipophilicity are crucial for the activity of these sesquiterpenes.
  • These marine compounds represent viable scaffolds for new drug development targeting Naegleria fowleri.

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...